EFORT CONGRESS LISBON 2022 | EXHIBITORS & SPONSORS LIST

Nested Applications

LIS22 Past EFORT Congress Exhibitions

PAST EFORT CONGRESS EXHIBITIONS

EFORT understands that in order to assess the relevance of your company exhibiting during 23rd EFORT Congress Lisbon 2022 – it is often useful to see which companies have exhibited at previous EFORT congresses. For your convenience, therefore, please find the complete exhibitor listings for the following annual congresses via the links below:

For any enquiries relating to exhibition, satellites and sponsorship – please contact by using the official exhibitors and sponsorship contact us online form.

Note* : The global Covid-19 pandemic forced EFORT to take the difficult decision to postpone the 21st and 22nd EFORT Annual Congresses that was formerly planned to be held in Vienna, Austria in June 2020 and June-July 2021 respectively.

Exhibitors Database 2022

EXHIBITORS AND PARTNERS LISTING 2022

EFORT invites you to browse through the Exhibitors Database of the 23rd EFORT Annual Congress Lisbon 2022 which represents those exhibitors that were present at the 2022 EFORT Congress held in Lisbon, Portugal from 22 to 24 June 2022.

EFORT Industry Database

Back to Exhibitors

Albomed GmbH

Hildebrandstrasse 11
90592 Schwarzenbruck
Germany
Phone: +49 (0) 9183 - 95 69 82-0
About Us

ALBOMED® GmbH is a German manufacturer of medical devices for Orthopaedics and Ophthalmology use.

ALBOMED is a leading quality-oriented company with more than 26 years’ experience in manufacturing of injectable products made from hyaluronic acid. ALBOMED fulfils the challenging requirements of the international market and provides its customers with products of excellent and certified quality.

The ALBOMED team offers to its business partners an authentic business development strategy based on fairness and competences with a comprehensive regulatory, marketing, and expert support. With an established international logistic pathway, the company offers reliable delivery schedules for shipments all over the world.

The company is experienced in implemented post-market clinical follow-up strategy for gathering of clinical evidence data, which includes investigations on clinical performance.

Area of Business: Orthopaedic and Ophthalmology Industry
Category: Medical Devices
Number of Employees worldwide: between 10 and 100
Founded in: 1995
Products
New generation viscosupplement for the treatment of osteoarthritis
ALBOMED GmbH designed a dedicated product for the needs of each patient. As manufacturer specialized in the development and commercialization of hyaluronic acid products, ALBOMED developed tailored intra-articular solutions for the relief of osteoarthritis patients. The orthopedics portfolio offers a complete range of viscosupplements with different concentrations of hyaluronic acid (from 1% to 2.5%) for all type of joints (1ml to 4.8ml) covering all the needs of the market and addressing the requirements of different phenotypes of osteoarthritis patients. Regularly investing in R&D, the company has recently launched an innovative formulation considered as the new generation viscosupplement. This new product has been designed to provide outstanding outcomes for the treatment of osteoarthritis, thanks to its reinforced viscoelastic properties.
Category: Intra-articular solutions for the relief of osteoarthritis patients
More information
// ]]>